彻底改变癌症治疗:在放射敏感化中使用单克隆抗体
Abolfazl Bemidinezhad1,2,3, Yasaman Abolhassani4, Mojgan Noroozi-Karimabad1
1Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
BioImpacts : BI
|October 9, 2025
概括
单克隆抗体 (mAbs) 通过改善瘤向和减少副作用来增强癌症放射治疗. 本综述探讨了它们的辐射敏感化机制以及组合疗法的未来潜力.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 辐射疗法 辐射疗法
背景情况:
- 放射治疗面临诸如健康组织损伤和瘤特异性差等挑战.
- 单克隆抗体 (mAbs) 提供有针对性的癌症治疗,毒性降低.
- mAbs显示了通过放射敏感化增强放射治疗疗效的潜力.
研究的目的:
- 在过去十年中,回顾mAbs在辐射敏感化中的多样性作用.
- 分析基于mAb的放射敏感化的关键机制,成功和挑战.
- 探索 mAb 交付系统中的新兴替代方案和进步.
主要方法:
- 文献综述综合了过去十年的发现.
- 对放射敏感化中的mAbs进行临床前和临床研究的分析.
- 讨论机制,挑战和替代方法.
主要成果:
- mAbs利用各种辐射敏感化机制,包括分子途径向和免疫调节.
- 在成功的临床前和临床应用mAbs在增强放射治疗.
- 确定的挑战包括输送效率低下,瘤耐药性和抗原异质性.
结论:
- mAbs是通过增强放射治疗来改善癌症治疗结果的有希望的策略.
- 在mAb传递系统和组合疗法方面的进步对于个性化癌症护理至关重要.
- 像体和纳米体这样的新兴替代品为当前的局限性提供了潜在的解决方案.
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
02:38Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K